IJGC Podcast

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Lilie Lin to discuss radiotherapy and novel agents in gynecologic cancers. Dr. Lin is an Associate Professor in the Department of Radiation Oncology at the University of Texas, MD Anderson Cancer Center where she focuses on the management of gynecologic malignancies. She is the principal investigator of multiple clinical trials testing novel agents combined with radiotherapy for gyn malignancies; she is also interested in using novel PET radiotracers to interrogate the tumor microenvironment. Read her article, “Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin,” here: https://ijgc.bmj.com/content/early/2020/03/18/ijgc-2020-001227

In this Podcast, our Editor-in-Chief, Dr. Pedro T Ramirez outlines the options for management of patients with gynecologic cancers during the global crisis of COVID-19.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Lea Moukarzel to discuss the ARIA Study and use of ICG in bowel surgery. Before starting her Gynecologic Oncology Fellowship at Memorial Sloan Kettering Cancer Center in 2018, Dr. Moukarzel completed her residency at Johns Hopkins Hospital. Dr. Moukarzel’s research involves the use of genomics and transcriptomics to investigate the genetic underpinning and immune microenvironment of gynecologic cancers as well as clinical work focused on improving surgical outcomes.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Soslow for a summary discussion PAOLA trial.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jonathan Ledermann to talk about the ICON8 Trial and its impact on clinical practice. Dr. Ledermann is a professor of medical oncology at UCL Cancer Institute specializing in the treatment and research of gynecological malignancies. He has been the Director of the Cancer Research UK and UCL Cancer Trials Centre for over 20 years and has led several national and international trials on the treatment of ovarian cancer. He has had a key role in developing trials of PARP inhibitors in ovarian cancer. Dr. Ledermann is a Fellow of the Academy of Medical Sciences and Senior Investigator for the National Institute of Health Research in the UK.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Soslow to talk about updates on endometrial cancer pathology. Rob Soslow has been the lead gynecologic pathologist at Memorial Sloan Kettering Cancer Center for nearly 20 years and has served on the executive committee of the International Society of Gynecological Pathologists, the council of the International Gynecologic Cancer Society and the editorial boards of several journals, including the International Journal for Gynecologic Cancer. He is an enthusiastic diagnostician, mentor, educator and investigator.

In this episode of the IJGC podcast, Dr. Michael Frumovitz, a Guest Editor on the March 2020 special issue on Advances in Lymphatic Mapping and Sentinel Lymph Node Biopsy in Gynecologic Cancers, is joined by Dr. Al Covens to discuss management of isolated tumor cells in sentinel nodes in women with cervical cancer. Dr. Coven's article, "Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?" is the Lead article for the issue (https://ijgc.bmj.com/content/early/2019/12/20/ijgc-2019-000928). Dr. Covens is the chair of Gyn Oncology at the University of Toronto, and the Head of Gyn Oncology at Sunnybrook Health Sciences Centre.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andrea Mariani to discuss lymphadenectomy vs. SLN: Mayo and Memorial Sloan Kettering experience. Dr. Andrea Mariani is a Full Professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Surgery, at Mayo Clinic in Rochester, Minnesota. His research interest is endometrial cancer with a special interest in robotic surgery. He is internationally recognized for his contributions in the advancement of surgical and postoperative treatment of endometrial cancer.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Koji Matsuo to discuss chemotherapy and radiation vs. radiation alone after radical hysterectomy. Dr. Matsuo is Associate Professor and Chief of the Oncology Research in the Division of Gynecologic Oncology at University of Southern California. Dr. Matsuo’s research focuses on outcomes research in gynecologic malignancies.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Ross Harrison to discuss fertility outcomes in women with endometrial hyperplasia or cancer. Before starting fellowship at MD Anderson Cancer Center in 2018, Dr. Harrison completed residency in obstetrics & gynecology at the University of Wisconsin. His research interests are related to the costs of cancer care, financial toxicity, and cost-effectiveness.